Alaris Infusion Pump

Alaris Infusion Pumps are designed to deliver fluids to the body in a controlled manner.  In 2019, Becton Dickson announced separate recalls for Alaris Infusion Pump Modules, Model 8100, and Alaris Pump Model 8100 Infusion Sets suspected of injuring patients.

Alaris Infusion Pump Modules and Infusion Sets

The Alaris Pump Module, Model 8100, is a component of the Alaris electronic infusion pump system. Hospitals and other healthcare facilities use the Alaris Infusion Pump Module to deliver medications, blood, or blood products into a patient’s body in a controlled manner. The Model 8100 is compatible with the Alaris 8000 and Alaris 8015 PCU Infusion Pump units, and is indicated for  adult, pediatric, and neonatal patients.

The Alaris Model 8100 Infusion Sets are comprised of:

  • Silicone tubing for placement in a patient’s vein or other route of administration, such as an artery or the epidural space of the spine;
  • Drip chamber; and
  • Check valve, to stop fluid administration as designated by the infusion pump.

The Alaris Infusion Pump Module, Model 8100, received marketing clearance through the U.S. Food & Drug Administration’s (FDA) 510(k) program, as did the corresponding Alaris Infusion Sets. This fast-track process allows manufacturers to avoid the time and expense of human testing if they can show that a new product is “substantially equivalent” to a device that has already been cleared for sale through the FDA’s stringent pre-market approval process.

Alaris Infusion Pump Recalls

Becton Dickson initially recalled Alaris Infusion Pump Modules, Model 8100, in September 2017, warning that a defect with the pumps’ bezels might cause the devices to deliver more or less of the desired dose. However, the  first Alaris Infusion Pump recall  only included the following products if their bezels were manufactured in October and November 2011:

  • Alaris Pump Modules Model 8100 manufactured between April 2011 and June 2017 that include FR-110 bezels.
  • Any Alaris Pump Modules serviced with LVP Mechanism Sub Assembly (P/N 10942012, P/N 49000007, and P/N 49000203).
  • Alaris Pump Module Bezel Kit Assembly (P/N 10964559 and P/N 49000204).

In April 2019,  Becton Dickson expanded the Alaris Infusion Pump recall to include any of the above products with bezels manufactured between April 2011 and June 2017.

The following month, Becton Dickson recalled  millions of Alaris Model 8100 Infusion Sets because of non-uniform thickness in the walls of the silicone tubes. This defect could cause tubal collapse or a failure to stop fluid administration as designated by the pump. Such an occurrence could actually lead to an overdose, placing the patient at risk for severe injury or even death.

Alaris Infusion Pump Recalls Designated Class I

The FDA has apparently received hundreds of MDR reports related to the Alaris Infusion Pump recalls, including reports of serious patient injuries.  As a result, the agency designated both actions Class I Medical Device Recalls.

Class I is the FDA’s most serious recall category. This designation indicates that there is a reasonable probability that the recalled Alaris Infusion Pump Module or recalled Alaris Infusion Sets will cause serious adverse health consequences or death.

  1. FDA (1995) “510(K) Premarket Notification – THE IMED ORION INFUSION PUMP AND ADMINISTRATION SETS”
  2. FDA (1989) “510(K) Premarket Notification – IMED GEMINI 12 NONVENTED Y-TYPE BLOOD/SOLUTION ADM”
  3. Becton Dickson (2017) “Recall Notification – Alaris Pump Module 8100”
  4. FDA (2019) “BD Provides Update on Voluntary Recalls of Alaris™ Pump Module Model 8100 and Certain Alaris Pump Infusion Sets”
  5. FDA (2019) “Becton Dickinson (BD) Recalls Alaris Infusion Sets for the Alaris Pump Model 8100 Due to Potential for Tube Collapse that May Cause Unintended Delivery or Faster than Expected Delivery of Medication”
Last Modified: July 26, 2019

Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.


Follow Us on Google+ on Facebook on LinkedIn on Twitter on YouTube on Pinterest

Skip to content